The stock is trading at 33.5x/27.9x its FY26/27 EPS. The management expects a 20% revenue growth for the next three years led mainly by ATBS and Antioxidants (AOs), with long term sustainable blended EBITDA margin of 26%-27% (including other income).
OutlookWe upgrade Vinati Organics to a ‘Buy’ rating from ‘Hold’ previously considering the expected momentum in ATBS sales. The company’s revenue/PAT are expected to clock a 19.8%/21.3% CAGR over FY24-27. We assign a multiple of 35x on its FY27 EPS and arrive at a TP of Rs. 2,000,
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Vinati Organics - 21032025 - khanDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
